Issue-1 Archives - Global Journal of Pharma Innovations GJPI

Association Between Panchakarma Session Completion and Magnitude of HbA1c Reduction in Type 2 Diabetes Mellitus: A Dose-Response Analysis from the Madhavbaug Comprehensive Diabetes Care Programme, Nagpur

Dr. Rohit Sane1, Dr. Gurudatta Amin2, Dr. Pravin Ghadigaonkar3, Dr. Aniket Kamble4, Dr Shweta Wahane5 MD and CEO, Vaidya Sane Ayurved Laboratories Limited1 Chief Medical

Download PDF »

June 18, 2026

Short-Term Outcomes of a Structured Ayurvedic Multimodal Protocol in Type 2 Diabetes Mellitus: Real-World Evidence from a Tier-2 Indian City

Dr. Rohit Sane1, Dr. Gurudatta Amin2, Dr. Pravin Ghadigaonkar3, Dr. Bipin Gond4, Dr. Swapnil Deshmukh5, Dr. Abrar Sagare6 MD and CEO, Vaidya Sane Ayurved Laboratories

Download PDF »

June 17, 2026

Comprehensive Glycaemic and Cardiometabolic Outcomes of the CDC DM Package at Navi Mumbai-Nerul: A Retrospective Analysis of 44 T2DM Patients with Significant HbA1c Reduction, Blood Pressure Control and Abdominal Girth Improvement

Dr. Rohit Sane1, Dr. Pravin Ghadigaonkar2, Dr. Gurudatta Amin3, Dr. Nilesh Kulthe4, Dr. Tejaswini Shingan5 MD and CEO, Vaidya Sane Ayurved Laboratories Limited1 Head Medical

Download PDF »

June 17, 2026

Effect of Integrative Ayurvedic Intervention (CDC Panchakarma Protocol with Low-Calorie Prameha Diet) on Glycemic Control and Cardiometabolic Parameters in Type 2 Diabetes: A Pre-Post Observational Study

Dr. Rohit Sane1, Dr. Gurudatta Amin2, Dr. Pravin Ghadigaonkar3, Dr. Priyadarshini Bhalekar4, Dr. Dhanashri Mahajan5, Dr. Neha Gosavi6 MD and CEO, Vaidya Sane Ayurved Laboratories

Download PDF »

June 17, 2026